Nektar Therapeutics (NKTR) Directors and Executive Officers - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Nektar Therapeutics  (NASDAQ: NKTR)

Nektar Therapeutics

Officers & Directors


1. Myriam J. Curet - Director -

2. Diana M. Brainard - Director -

3. Robert B. Chess - Director, Chairman of the Board of Directors -

4. Jeffrey R. Ajer - Director -

5. R. Scott Greer - Director -

6. Sandra Gardiner - Interim Chief Financial Officer (Principal Financial and Accounting Officer) -

7. Roy A. Whitfield - Director -

8. Howard W. Robin - Chief Executive Officer, President, and Director -

9. Sandra Gardiner - Interim Chief Financial Officer - ,

Nektar Therapeutics currently has 63 employees.






NKTR Management Effectiveness NKTR Revenue per Employee NKTR Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.